120 related articles for article (PubMed ID: 31453862)
1. Platelet-lymphocyte and neutrophil-lymphocyte ratios: Predictive factors of response and toxicity for docetaxel-combined induction chemotherapy in advanced head and neck cancers.
Liu YH; Lin YS
J Chin Med Assoc; 2019 Nov; 82(11):849-855. PubMed ID: 31453862
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Hematological Inflammatory Markers in Predicting Severe Side-effects from Induction Chemotherapy in Head and Neck Cancer Patients.
Mikoshiba T; Ozawa H; Saito S; Ikari Y; Nakahara N; Ito F; Watanabe Y; Sekimizu M; Imanishi Y; Ogawa K
Anticancer Res; 2019 Jun; 39(6):3059-3065. PubMed ID: 31177149
[TBL] [Abstract][Full Text] [Related]
3. [Toxicity of docetaxel, platine, 5-fluorouracil-based induction chemotherapy for locally advanced head and neck cancer: The importance of nutritional status].
Bernadach M; Lapeyre M; Dillies AF; Miroir J; Moreau J; Kwiatkowski F; Pham-Dang N; Saroul N; Durando X; Biau J
Cancer Radiother; 2019 Jul; 23(4):273-280. PubMed ID: 31138520
[TBL] [Abstract][Full Text] [Related]
4. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
8. Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.
Wang TY; Chen WM; Yang LY; Chen CY; Chou WC; Chen YY; Chen CC; Lee KD; Lu CH
Support Care Cancer; 2016 Nov; 24(11):4697-703. PubMed ID: 27329415
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Histologic Predictive Factors of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
Karpathiou G; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Gavid M; Peoc'h M
Am J Clin Pathol; 2016 Nov; 146(5):546-553. PubMed ID: 27694130
[TBL] [Abstract][Full Text] [Related]
10. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
11. The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer.
Liu D; Jin J; Zhang L; Li L; Song J; Li W
Cell Physiol Biochem; 2018; 46(4):1595-1605. PubMed ID: 29694985
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
13. Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
Nakashima T; Yasumatsu R; Asai K; Uryu H; Kogo R; Nakagawa T
Int J Clin Oncol; 2017 Jun; 22(3):442-447. PubMed ID: 28062933
[TBL] [Abstract][Full Text] [Related]
14. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
15. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience.
Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N
Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860
[TBL] [Abstract][Full Text] [Related]
16. Response Rate of Cisplatin Plus Docetaxel as Primary Treatment in Locally Advanced Head and Neck Carcinoma (Squamous Cell Types).
Nouman M; Haider G; Bukhari N; Yousuf A; Nouman R; Shaikh MR; Hussain S; Pavan B; Rahool R; Memon P; Zahoor S; Mehar K; Sami A
Asian Pac J Cancer Prev; 2020 Mar; 21(3):825-830. PubMed ID: 32212813
[TBL] [Abstract][Full Text] [Related]
17. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
Okano S; Enokida T; Onoe T; Ota Y; Motegi A; Zenda S; Akimoto T; Tahara M
Int J Clin Oncol; 2019 Jul; 24(7):789-797. PubMed ID: 30796560
[TBL] [Abstract][Full Text] [Related]
18. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
[TBL] [Abstract][Full Text] [Related]
20. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]